Literature DB >> 7593868

Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment.

T A Brown1, D H Barlow.   

Abstract

Long-term outcome (24-month follow-up; 24MFU) of cognitive-behavioral treatment was examined in 63 patients with panic disorder. When the traditional methods of cross-sectional assessment were used (e.g., panic frequency during past month), long-term outcome findings paralleled those of earlier studies. However, assessments of idiographic response and those that examined longer time periods revealed that a large proportion of the sample experienced a fluctuating symptom course of panic-related symptomatology that was not captured by the cross-sectional method. Many (27%) patients sought further treatment for panic during the follow-up period because of a less-than-adequate response to treatment; nevertheless, additional treatment did not result in further clinical improvement. Pretreatment severity of panic disorder was associated with poorer outcome at 24MFU. Use of psychotropic medication during treatment was associated with poorer outcome, although to a weaker degree when pretreatment responding was controlled. Findings are discussed in the context of how the outcome of treatments for panic disorder should be evaluated and interpreted.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593868     DOI: 10.1037//0022-006x.63.5.754

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  28 in total

1.  Treatment of Social Phobia: Potential Mediators and Moderators.

Authors:  Stefan G Hofmann
Journal:  Clin Psychol (New York)       Date:  2000-03

Review 2.  Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.

Authors:  T A Furukawa; N Watanabe; R Churchill
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 3.  Treatment for anxiety disorders: Efficacy to effectiveness to implementation.

Authors:  Michelle G Craske; Peter P Roy-Byrne; Murray B Stein; Greer Sullivan; Cathy Sherbourne; Alexander Bystritsky
Journal:  Behav Res Ther       Date:  2009-07-14

4.  Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial.

Authors:  J MacLaren Kelly; Ewgeni Jakubovski; Michael H Bloch
Journal:  J Clin Psychiatry       Date:  2015-03       Impact factor: 4.384

Review 5.  Coping skills and exposure therapy in panic disorder and agoraphobia: latest advances and future directions.

Authors:  Alicia E Meuret; Kate B Wolitzky-Taylor; Michael P Twohig; Michelle G Craske
Journal:  Behav Ther       Date:  2011-08-27

6.  Psychiatric Symptom Improvement in Women Following Group Substance Abuse Treatment: Results from the Women's Recovery Group Study.

Authors:  R Kathryn McHugh; Shelly F Greenfield
Journal:  J Cogn Psychother       Date:  2010-04-01

Review 7.  Pharmacological enhancement of fear reduction: preclinical models.

Authors:  Bronwyn M Graham; Julia M Langton; Rick Richardson
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

8.  Computer-assisted delivery of cognitive behavioral therapy for anxiety disorders in primary-care settings.

Authors:  Michelle G Craske; Raphael D Rose; Ariel Lang; Stacy Shaw Welch; Laura Campbell-Sills; Greer Sullivan; Cathy Sherbourne; Alexander Bystritsky; Murray B Stein; Peter P Roy-Byrne
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 9.  Panic control treatment and its applications.

Authors:  S G Hofmann; D A Spiegel
Journal:  J Psychother Pract Res       Date:  1999

10.  Psychosocial predictors of the onset of anxiety disorders in women: results from a prospective 3-year longitudinal study.

Authors:  Amanda W Calkins; Michael W Otto; Lee S Cohen; Claudio N Soares; Alison F Vitonis; Bridget A Hearon; Bernard L Harlow
Journal:  J Anxiety Disord       Date:  2009-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.